Rajinder Singh

Rajinder Singh

Auto-generated profile, based on publicly available information

Rajinder Singh

Cancer Biomarkers and Prevention Group, Biocentre, University of Leicester, University Road, Leicester LE1 7RH, UK

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2019 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
LHLynne Howells
Lynne Howells
CIChinenye O O Iwuji
Chinenye O O Iwuji
GIGlen R B Irving
Glen R B Irving
SBShaun Barber
Shaun Barber
HWHarriet Walter
Harriet Walter
KBKaren Brown
Karen Brown
Curcumin is the main active ingredient of the spice turmeric, investigated extensively for putative anticancer properties. This phase IIa open-labelled randomized controlled trial aimed to assess safety, efficacy, quality of life, neurotoxicity, curcuminoids, and C-X-C-motif chemokine ligand 1 (CXCL1) in patients receiving folinic acid/5-fluorouracil/oxaliplatin chemotherapy (FOLFOX) compared with FOLFOX + 2 g oral curcumin/d (CUFOX). Twenty-eight patients aged >18 y with a histological diagnosis of metastatic colorectal cancer were randomly assigned (1:2) to receive either FOLFOX or CUFOX. Safety was assessed by Common Toxicity Criteria-Adverse Event reporting, and efficacy via progression-free survival (PFS) and overall survival (OS). Quality of life and neurotoxicity were assessed using questionnaires (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and Functional Assessment of Cancer Treatment-Gynecologic Oncology Group-Neurotoxicity). Plasma curcuminoids were determined with liquid chromatography (LC) electrospray ionization tandem mass spectrometry and CXCL1 by ELISA. Addition of daily oral curcumin to FOLFOX chemotherapy was safe and tolerable (primary outcome). Similar adverse event profiles were observed for both arms. In the intention-to-treat population, the HR for PFS was 0.57 (95% CI: 0.24, 1.36; P = 0.2) (median of 171 and 291 d for FOLFOX and CUFOX, respectively) and for OS was 0.34 (95% CI: 0.14, 0.82; P = 0.02) (median of 200 and 502 d for FOLFOX and CUFOX, respectively). There was no significant difference between arms for quality of life (P = 0.248) or neurotoxicity (P = 0.223). Curcumin glucuronide was detectable at concentrations >1.00 pmol/mL in 15 of 18 patients receiving CUFOX. Curcumin did not significantly alter CXCL1 over time (P = 0.712). Curcumin is a safe and tolerable adjunct to FOLFOX chemotherapy in patients with metastatic colorectal cancer. This trial was registered at clinicaltrials.gov as NCT01490996 and at www.clinicaltrialsregister.eu as EudraCT 2011-002289-19.

4 November 2005 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
RSRajinder Singh
Rajinder Singh
PFPeter B. Farmer
Peter B. Farmer
Over the past 40 years considerable emphasis has been placed on the development of accurate and sensitive methods for the detection and quantitation of DNA adducts. The formation of DNA adducts resulting from the covalent interaction of genotoxic carcinogens with DNA, derived from exogenous and endogenous sources, either directly or following metabolic activation, can if not repaired lead to mutations in critical genes such as those involved in the regulation of cellular growth and subsequent development of cancer. The major analytical challenge has been to detect levels of DNA adducts at the level of 0.1–1 adducts per 10 8 unmodified DNA bases using only low microgram amounts of DNA, and with high specificity and accuracy, in humans exposed to genotoxic carcinogens derived from occupational, environmental, dietary and life-style sources. In this review we will highlight the merits as well as discuss the progress made by liquid chromatography coupled to electrospray ionization mass spectrometry as a method for DNA adduct detection.

1 July 2007 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
RSRajinder Singh
Rajinder Singh
RSRadim J. Sram
Radim J. Sram
BBBlanka Binkova
Blanka Binkova
IKIvan Kalina
Ivan Kalina
TPTodor Popov
Todor Popov
PFPeter B. Farmer
Peter B. Farmer

2 December 2002 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Open access
PDF file
RSRajinder Singh
Rajinder Singh
MMMichael McEwan
Michael McEwan
JLJohn H. Lamb
John H. Lamb
RSRegina M. Santella
Regina M. Santella
PFPeter B. Farmer
Peter B. Farmer
The analysis of 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents an important biomarker of oxidative stress. A sensitive method for the detection of 8‐oxodG in DNA samples has been developed that utilizes immunoaffinity column purification of 8‐oxodG followed by liquid chromatography/mass spectrometry/mass spectrometry (LC/MS/MS) multiple reaction monitoring (MRM) mode analysis. An internal standard of stable‐isotopically labelled 8‐oxodG containing [ 15 N 5 ] was added prior to the enzymatic digestion of DNA to deoxynucleosides, which was then subjected to immunoaffinity column purification followed by microbore positive ion LC/MS/MS MRM. The 8‐oxo‐7,8‐dihydroguanine (8‐oxoG) base product ion at m/z 168 was monitored following cleavage of the glycosidic bond of the 8‐oxodG [M+H] + ion at m/z 284. Similar determinations were made for [ 15 N 5 ]8‐oxodG by monitoring the [ 15 N 5 ]8‐oxoG base product ion at m/z 173 formed from the [M+H] + ion at m/z 289. The introduction of the immunoaffinity column purification step into the method represents a significant improvement for the accurate determination of 8‐oxodG since all artefactual peaks that are observed following the direct injection of digested DNA onto the LC/MS/MS system are removed. The identity of these artefactual peaks has been confirmed to be 2′‐deoxyguanosine (dG), thymidine (dT) and 2′‐deoxyadenosine (dA). The presence of these artefactual peaks in MRM mode analysis can be explained as a consequence of a concentration effect due to their considerably higher relative abundance in DNA compared to 8‐oxodG. The highest signal intensity was observed for the artefactual peak for dA due to the fact that the adenine base formed an adduct with methanol, which is a constituent of the mobile phase. The resulting [M+H] + ion at m/z 284 (dA m/z 252 + CH 3 OH m/z 32) gave rise to a product ion at m/z 168 following the loss of deoxyribose in MRM mode analysis. Control calf thymus DNA was digested to deoxynucleosides and unmodfied deoxynucleosides were removed by immunoaffinity column purification; the enriched 8‐oxodG was determined by LC/MS/MS MRM. The level of 8‐oxodG in control calf thymus DNA was determined to be 28.8 ± 1.2 8‐oxodG per 10 6 unmodified nucleotides (n = 5) using 5 μg of digested DNA. The limit of detection of the microbore LC/MS/MS MRM for 8‐oxodG was determined to be 25 fmol on‐column with a signal‐to‐noise ratio of 3.5. Copyright © 2002 John Wiley & Sons, Ltd.

1 December 2021 in Nano Today
Verified
Journal Article
Open access
SPStanislav S. Piletsky
Stanislav S. Piletsky
Elena PiletskaElena Piletska
Elena Piletska
MPMarta Poblocka
Marta Poblocka
SMSalvador Macip
Salvador Macip
DJDonald J.L. Jones
Donald J.L. Jones
SPSergey A. Piletsky
Sergey A. Piletsky

1 July 2007 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
RSRajinder Singh
Rajinder Singh
BKBalvinder Kaur
Balvinder Kaur
IKIvan Kalina
Ivan Kalina
TPTodor Popov
Todor Popov
Tzveta Petrova GeorgievaTzveta Petrova Georgieva
Tzveta Petrova Georgieva
PFPeter B. Farmer
Peter B. Farmer